The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients

BACKGROUND/AIMS: The efficacy and safety of a combination of ezetimibe and low-dose statin as primary treatment for dyslipidemia in renal transplant patients were evaluated prospectively. METHODS: The study enrolled 77 renal transplant recipients with dyslipidemia. They were given ezetimibe (10 mg)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hye Eun, Song, Joon Chang, Hyoung, Bok Jin, Hwang, Hyeon Seok, Lee, So Young, Jeon, Youn Joo, Choi, Bum Soon, Kim, Yong Soo, Yang, Chul Woo
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732783/
https://www.ncbi.nlm.nih.gov/pubmed/19721860
http://dx.doi.org/10.3904/kjim.2009.24.3.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732783/
https://www.ncbi.nlm.nih.gov/pubmed/19721860
http://dx.doi.org/10.3904/kjim.2009.24.3.233

Ejemplares similares